We wanted to show that development material faces the same risks as commercial material in the supply chain and that a study can be performed in a way that creates value, while at the same time conserving resources.
Bloomington, IN (PRWEB) August 07, 2014
BioConvergence prepares to host its next webinar, “Shipping Lane Qualification: A Risk-Based, Efficient Approach”, on August 13th at 1:00 p.m. EDT. The presenters, Travis Hudson and Carl Rush, have developed this webinar to include discussion of the costs and benefits of conducting shipping lane qualification studies, potential challenges that can be encountered, and examples of how BioConvergence overcame those challenges when performing this type of shipping lane qualification.
When discussing why they chose this topic, Hudson states, “More often than not, shipping lane qualifications are performed by large commercial firms with large amounts of product traversing repeated lanes. We wanted to show that development material faces the same risks as commercial material in the supply chain and that a study can be performed in a way that creates value, while at the same time conserving resources.”
The webinar is targeted towards small- to mid-size pharmaceutical companies. Employees responsible for maintaining product security and viability for temperature-controlled development materials through the supply chain should attend. Also, personnel interested in learning when it is appropriate to perform a shipping lane qualification should attend. Hudson and Rush will illustrate how to design and execute a shipping lane qualification in a way that creates value and mitigates risk.
Another benefit of attending the webinar is the availability of a shipping lane qualification risk-assessment questionnaire for companies to implement in their own decision-making processes. All webinar attendees will be entered into a drawing for a $50 Amazon gift card.
To learn more about performing a shipping lane qualification, consult Hudson’s blog post: “3 Steps to Determine Need for Shipping Lane Qualification.”
Does this topic interest you? Could it benefit your company? Register for the webinar today. Space is limited.
BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, BioConvergence has over 50 employees with more than five centuries’ worth of combined experience in the pharmaceutical industry. The unique E-Transparency® System provides transparency and flexibility to clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.